Allogene Therapeutics · NASDAQ: ALLO · Biotechnology
Over the past week, Allogene Therapeutics (ALLO) saw about 14 mentions across Reddit, X and news, and the read is an Adanos Buy. The crowd averages 63% bullish but is far apart: News runs 100% bullish while X sits at just 33%. Wall Street is more constructive, with 12 of 14 analysts rating ALLO a buy.
There is little buzz around ALLO this week and little agreement on direction, which is why it reads as a Buy.
Wall Street’s 86% buy share sits next to a crowd that ranges from X at 33% to News at 100%. No other tracker puts the two side by side.
Across 14 analysts the consensus is a Strong Buy: 12 buy calls against 0 sell, with an average 12-month price target of $8.48.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits above the neutral line, momentum is improving and the 3 sources disagree sharply, so the read is a Buy.
Analysts sit 23 points above the crowd average of 63%, the professionals are more constructive than retail. The split is inside the crowd: News reads 100% bullish while X sits at 33%, a 67-point spread that single-source trackers miss.
Over the 30-day window, Allogene Therapeutics (ALLO) buzz held subdued around 28.5 while the price drifted up 3.1% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 11.3M shares. Updated Jul 13, 2026. Over the last 7 trading days, ALLO lost 5.2%. Buzz activity in the recent week averaged 40.6 and was variable, swinging between 28.5 and 52.6. Recent volume is in line with the 30-day average, reflecting steady institutional and retail participation. Daily crowd sentiment leaned bullish on 4 of the 8 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Buzz, bullish share, the loudest item and the positive / neutral / negative split for every tracked source over the last 7 days.
No Polymarket data for this stock this week.
Query sentiment for ALLO and 1000+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live ALLO sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Jul 13, 2026.
Based on aggregated sentiment from Reddit, X and News sources, Allogene Therapeutics (ALLO) currently carries an Adanos buy signal with 93/100 conviction. The current cross-source average reads 63% bullish across 3 active sources. Those sources contribute 14 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Allogene Therapeutics (ALLO) is fairly quiet with 7 mentions across 2 tracked subreddits. The tone is 57% bullish with stable 3-day activity momentum, suggesting steady attention.
Allogene Therapeutics (ALLO) sentiment is bullish across all 3 tracked sources. Reddit reads 57% bullish, News reads 100% bullish and x coverage is the most negative at 33% bullish. The combined signal points to broad buy-side pressure with 93/100 conviction.
Social sentiment data shows consistently bullish discussion around Allogene Therapeutics (ALLO). All 3 tracked sources lean positive, with x being the most bearish at 33% bullish. 3-day activity momentum is rising across News. The buy signal carries 93/100 conviction.
Reddit is the dominant discussion channel with 7 mentions (50% of total volume). X contributes 6 mentions and News contributes 1 mentions. Sentiment is bullish across all sources, while news is the only source with rising 3-day activity.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. ALLO's buy signal at 93/100 conviction reflects consistently bullish sentiment across multiple platforms. It is a research shortcut, not financial advice.
The ALLO sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
These stocks share a comparable sentiment profile to Allogene Therapeutics with similar bullish ratios, signal direction and discussion volume. All 6 peers carry buy signals, pointing to broad bullish pressure rather than an ALLO-specific issue.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key